Perrigo Company plc (PRGO) |
|
35.87 0.47 (1.33%)
|
03-31 16:00 |
|
Open: |
35.61 |
Pre. Close: |
35.4 |
|
High:
|
35.9 |
Low:
|
35.585 |
|
Volume:
|
769,292 |
Market Cap:
|
4,846(M) |
|
|
|
Technical analysis |
as of: 2023-03-31 4:21:24 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 45.28  One year: 52.89 |
| Support: |
Support1: 35.17 Support2: 32.95 |
| Resistance: |
Resistance1: 38.77 Resistance2: 45.28 |
| Pivot: |
34.87 |
| Moving Average: |
MA(5): 35.03 MA(20): 35.34 
MA(100): 34.78 MA(250): 37.22 |
| MACD: |
MACD(12,26): -0.4 Signal(9): -0.5 |
| Stochastic oscillator: |
%K(14,3): 71.3 %D(3): 53.5 |
| RSI: |
RSI(14): 53.3 |
| 52-week: |
High: 43.9 Low: 30.78 |
| Average Vol(K): |
3-Month: 1,072 (K) 10-Days: 982 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PRGO ] has closed below upper band by 17.5%. Bollinger Bands are 30.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
35.91 - 36.02 |
36.02 - 36.14 |
|
Low:
|
35.26 - 35.39 |
35.39 - 35.54 |
|
Close:
|
35.63 - 35.83 |
35.83 - 36.05 |
|
Company Description |
|
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. |
Headline News |
Fri, 31 Mar 2023
Perrigo Co. PLC stock rises Friday, still underperforms market - MarketWatch
Thu, 30 Mar 2023
Perrigo Company Plc $PRGO Technical Pivots with Risk Controls - Stock Traders Daily
Wed, 29 Mar 2023
Rothschild Investment Corp IL Increases Stake in Perrigo Company ... - Best Stocks
Wed, 29 Mar 2023
DAVENPORT & Co LLC Boosts Holdings in Perrigo Company plc ... - MarketBeat
Tue, 28 Mar 2023
Perrigo Announces New Date for Joint FDA Advisory Committee ... - Perrigo Investor Relations
Sun, 26 Mar 2023
Ridgewood Investments LLC Acquires 17779 Shares of Perrigo ... - MarketBeat
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
135 (M) |
| Shares Float |
134 (M) |
|
% Held by Insiders
|
1 (%) |
|
% Held by Institutions
|
100.5 (%) |
|
Shares Short
|
5,630 (K) |
|
Shares Short P.Month
|
5,080 (K) |
Stock Financials |
|
EPS
|
-0.94 |
|
EPS Est Next Qtl
|
1.22 |
|
EPS Est This Year
|
4.59 |
|
EPS Est Next Year
|
5.11 |
|
Book Value (p.s.)
|
35.95 |
|
Profit Margin (%)
|
-3.2 |
|
Operating Margin (%)
|
3.7 |
|
Return on Assets (ttm)
|
0.9 |
|
Return on Equity (ttm)
|
-2.7 |
|
Qtrly Rev. Growth
|
4.5 |
|
Gross Profit (p.s.)
|
10.84 |
|
Sales Per Share
|
33.04 |
|
EBITDA (p.s.)
|
3.76 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
307 (M) |
|
Levered Free Cash Flow
|
287 (M) |
Stock Valuations |
|
PE Ratio
|
-38.15 |
|
PEG Ratio
|
1.3 |
|
Price to Book value
|
0.99 |
|
Price to Sales
|
1.08 |
|
Price to Cash Flow
|
15.71 |
Stock Dividends |
|
Dividend
|
0.27 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0.7% |
|
Dividend Pay Date
|
2021-12-20 |
|
Ex-Dividend Date
|
2021-12-01 |
|
Your Ad Here
|
|
